Comment
Author: Admin | 2025-04-28
Caution/Monitor.thioridazinecyclobenzaprine and thioridazine both increase sedation. Use Caution/Monitor.cyclobenzaprine decreases levels of thioridazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.cyclobenzaprine decreases levels of thioridazine by pharmacodynamic antagonism. Use Caution/Monitor.thioridazine increases effects of cyclobenzaprine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.thiothixenecyclobenzaprine and thiothixene both increase sedation. Use Caution/Monitor.cyclobenzaprine decreases levels of thiothixene by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.cyclobenzaprine decreases levels of thiothixene by pharmacodynamic antagonism. Use Caution/Monitor.thiothixene increases effects of cyclobenzaprine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.tiotropiumcyclobenzaprine and tiotropium both decrease cholinergic effects/transmission. Use Caution/Monitor.tolterodinecyclobenzaprine and tolterodine both decrease cholinergic effects/transmission. Use Caution/Monitor.topiramatecyclobenzaprine and topiramate both increase sedation. Modify Therapy/Monitor Closely.tramadolcyclobenzaprine and tramadol both increase sedation. Use Caution/Monitor.trazodonecyclobenzaprine and trazodone both increase sedation. Use Caution/Monitor.triazolamtriazolam and cyclobenzaprine both increase sedation. Use Caution/Monitor.triclofostriclofos and cyclobenzaprine both increase sedation. Use Caution/Monitor.trifluoperazinecyclobenzaprine and trifluoperazine both increase sedation. Use Caution/Monitor.cyclobenzaprine decreases levels of trifluoperazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.cyclobenzaprine decreases levels of trifluoperazine by pharmacodynamic antagonism. Use Caution/Monitor.trifluoperazine increases effects of cyclobenzaprine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.trihexyphenidylcyclobenzaprine and trihexyphenidyl both decrease cholinergic effects/transmission. Use Caution/Monitor. Potential for additive anticholinergic effects.trimipraminecyclobenzaprine and trimipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.cyclobenzaprine and trimipramine both increase sedation. Use Caution/Monitor.trospium chloridecyclobenzaprine and trospium chloride both decrease cholinergic effects/transmission. Use Caution/Monitor.vecuroniumcyclobenzaprine and vecuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.xylometazolinecyclobenzaprine increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.ziconotidecyclobenzaprine and ziconotide both increase sedation. Use Caution/Monitor.ziprasidonecyclobenzaprine and ziprasidone both increase sedation. Use Caution/Monitor.cyclobenzaprine decreases levels of ziprasidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.cyclobenzaprine decreases levels of ziprasidone by pharmacodynamic antagonism. Use Caution/Monitor.ziprasidone increases effects of cyclobenzaprine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.zotepinecyclobenzaprine and zotepine both increase sedation. Use Caution/Monitor.cyclobenzaprine decreases levels of zotepine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.cyclobenzaprine decreases levels of zotepine by pharmacodynamic antagonism. Use Caution/Monitor.
Add Comment